These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2647953)

  • 1. Clinical experience with desmopressin: efficacy and safety in central diabetes insipidus and other conditions.
    Harris AS
    J Pediatr; 1989 Apr; 114(4 Pt 2):711-8. PubMed ID: 2647953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desmopressin for diabetes insipidus, hemostatic disorders and enuresis.
    Shulman LH; Miller JL; Rose LI
    Am Fam Physician; 1990 Oct; 42(4):1051-7. PubMed ID: 2220513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desmopressin.
    Richardson DW; Robinson AG
    Ann Intern Med; 1985 Aug; 103(2):228-39. PubMed ID: 3893256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modern approach in treatment of diabetes insipidus.
    Kapić E; Becić F; Todić M
    Bosn J Basic Med Sci; 2005 May; 5(2):38-42. PubMed ID: 16053453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, safety, and dosing of desmopressin for nocturnal enuresis in Europe.
    Hjälmås K; Bengtsson B
    Clin Pediatr (Phila); 1993 Jul; Spec No():19-24. PubMed ID: 8039334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma pharmacokinetics of desmopressin following sublingual administration: an exploratory dose-escalation study in healthy male volunteers.
    Steiner IM; Kaehler ST; Sauermann R; Rinösl H; Müller M; Joukhadar C
    Int J Clin Pharmacol Ther; 2006 Apr; 44(4):172-9. PubMed ID: 16625986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [DDAVP in the treatment of hypophyseal diabetes, nocturnal enuresis and in rapid determination of the concentrating function of the kidney].
    Likhardus V; Nemetova V; Legotska V
    Sov Med; 1976 Oct; (10):106-9. PubMed ID: 1023360
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effectiveness of and tolerability to oral desmopressin in the treatment of central diabetes insipidus].
    Merola B; Caruso E; De Chiara G; Rossi E; Longobardi S; Colao A; Brusco G; Lombardi G; Biraghi M
    Minerva Med; 1992 Dec; 83(12):805-13. PubMed ID: 1491760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics, pharmacodynamics, long-term efficacy and safety of oral 1-deamino-8-D-arginine vasopressin in adult patients with central diabetes insipidus.
    Lam KS; Wat MS; Choi KL; Ip TP; Pang RW; Kumana CR
    Br J Clin Pharmacol; 1996 Sep; 42(3):379-85. PubMed ID: 8877030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desmopressin for nocturnal enuresis in nephrogenic diabetes insipidus.
    Müller D; Marr N; Ankermann T; Eggert P; Deen PM
    Lancet; 2002 Feb; 359(9305):495-7. PubMed ID: 11853799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a new antidiuretic agent, desmopressin acetate (DDAVP).
    Kosman ME
    JAMA; 1978 Oct; 240(17):1896-7. PubMed ID: 691204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of central diabetes insipidus in adults and children with desmopressin.
    Ziai F; Walter R; Rosenthal IM
    Arch Intern Med; 1978 Sep; 138(9):1382-5. PubMed ID: 686929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study.
    Arima H; Oiso Y; Juul KV; Nørgaard JP
    Endocr J; 2013; 60(9):1085-94. PubMed ID: 23811987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased renal concentrating ability after long-term oral desmopressin lyophilisate treatment contributes to continued success for monosymptomatic nocturnal enuresis.
    Ikeda H; Watanabe T; Isoyama K
    Int J Urol; 2017 Sep; 24(9):698-702. PubMed ID: 28636262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Claiming desmopressin therapeutic equivalence in children requires pediatric data: a population PKPD analysis.
    Michelet R; Dossche L; Van Herzeele C; Van Bocxlaer J; Vermeulen A; Vande Walle J;
    Eur J Clin Pharmacol; 2018 Mar; 74(3):297-305. PubMed ID: 29198064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desmopressin acetate in children with severe primary nocturnal enuresis.
    Miller K; Klauber GT
    Clin Ther; 1990; 12(4):357-66. PubMed ID: 2224950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desmopressin 30 years in clinical use: a safety review.
    Vande Walle J; Stockner M; Raes A; Nørgaard JP
    Curr Drug Saf; 2007 Sep; 2(3):232-8. PubMed ID: 18690973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new fast-melting oral formulation of desmopressin: a pharmacodynamic study in children with primary nocturnal enuresis.
    Vande Walle JG; Bogaert GA; Mattsson S; Schurmans T; Hoebeke P; Deboe V; Norgaard JP;
    BJU Int; 2006 Mar; 97(3):603-9. PubMed ID: 16469035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desmopressin for nocturnal enuresis.
    Med Lett Drugs Ther; 1990 Apr; 32(816):38-9. PubMed ID: 2182991
    [No Abstract]   [Full Text] [Related]  

  • 20. Desmopressin (DDAVP) for enuresis, diabetes insipidus, and..
    Gaines KK
    Urol Nurs; 2004 Dec; 24(6):520-3. PubMed ID: 15658741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.